Provided by Tiger Fintech (Singapore) Pte. Ltd.

Optinose Inc.

9.16
+0.01000.11%
Volume:53.14K
Turnover:486.33K
Market Cap:92.26M
PE:-4.32
High:9.19
Open:9.10
Low:9.10
Close:9.15
Loading ...

BUZZ-Optinose rises on Paratek Pharma's acquisition deal of up to $330 million

Reuters
·
20 Mar

OptiNose Surges Premarket Following Acquisition Agreement With Paratek Pharmaceuticals for Up to $330 Million

MT Newswires Live
·
20 Mar

Optinose Shares Surge Premarket on Takeover Deal With Paratek

Dow Jones
·
20 Mar

OptiNose Shares up 58.3% at $9.50 Premarket After Paratek Pharmaceuticals to Acquire Co in $14/Share Deal

THOMSON REUTERS
·
20 Mar

Press Release: Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE(R) in Chronic Rhinosinusitis (CRS)

Dow Jones
·
20 Mar

Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call

GlobeNewswire
·
20 Mar

Paratek Pharmaceuticals To Acquire Optinose for Up To $330 Million

Reuters
·
20 Mar

Paratek Pharmaceuticals- Potential Consideration of up to $14 per Share, Including Upfront Consideration of $9 per Share

THOMSON REUTERS
·
20 Mar

OptiNose Inc expected to post a loss of 72 cents a share - Earnings Preview

Reuters
·
18 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
17 Mar

OptiNose (NASDAQ:OPTN) shareholders have endured a 90% loss from investing in the stock five years ago

Simply Wall St.
·
13 Mar

Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
12 Mar

Hansa Biopharma completes enrolment in European Phase 3 20-HMedIdeS-19 Post Authorization Efficacy and Safety study in highly sensitized kidney transplant patients

PR Newswire
·
11 Mar

OptiNose Inc expected to post a loss of 72 cents a share - Earnings Preview

Reuters
·
07 Mar

OptiNose trading resumes

TIPRANKS
·
04 Mar

OptiNose trading halted, volatility trading pause

TIPRANKS
·
04 Mar

OptiNose Inc expected to post a loss of 72 cents a share - Earnings Preview

Reuters
·
03 Mar

Optinose price target adjusted for stock split at Lake Street

TipRanks
·
17 Jan

Optinose Is Maintained at Buy by Lake Street

Dow Jones
·
17 Jan

OptiNose: Prelim, Unaudited Xhance Net Product REV of $22.4 Mln for Three Months Ended Dec 31, 2024

THOMSON REUTERS
·
15 Jan